SILEXION THERAPEUTICS CORP Other Noncash Expense
SILEXION THERAPEUTICS CORP (SLXN) reported Other Noncash Expense of $229.00 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashExpense · last filed 2025-08-12
- SILEXION THERAPEUTICS CORP other noncash expense for the quarter ending 2025-06-30 was $229.00K, a 175.90% increase year-over-year.
- SILEXION THERAPEUTICS CORP other noncash expense for the quarter ending 2025-03-31 was $81.00K, a 40.44% decline year-over-year.
- SILEXION THERAPEUTICS CORP other noncash expense for the quarter ending 2024-09-30 was $3.75M, a 3371.30% increase year-over-year.
- SILEXION THERAPEUTICS CORP other noncash expense for the quarter ending 2024-06-30 was $83.00K, a 70.14% decline year-over-year.
| Period end | Other Noncash Expense 3 month | Other Noncash Expense 6 month | Other Noncash Expense 9 month |
|---|---|---|---|
| 2025-06-30 | $229.00K 10-Q · filed 2025-08-12 | $310.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $81.00K 10-Q · filed 2025-05-13 | ||
| 2024-09-30 | $3.75M 10-Q · filed 2024-11-14 | $3.83M derived: sum of 2 quarters · filed 2025-08-12 | $3.97M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $83.00K 10-Q · filed 2025-08-12 | $219.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $136.00K 10-Q · filed 2025-05-13 | ||
| 2023-09-30 | $108.00K 10-Q · filed 2024-11-14 | $386.00K derived: sum of 2 quarters · filed 2024-11-14 | $365.00K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $278.00K 10-Q · filed 2024-08-29 | $257.00K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |